Plante Moran Financial Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Plante Moran Financial Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362	Buy	+10	New	+$342	﹤0.01%	1236

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Plante Moran Financial Advisors's COLL Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 10 shares worth $362. The stake represents ﹤0.01% of the portfolio and ranks #1236 among its holdings.

112 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Plante Moran Financial Advisors held 10 shares of Collegium Pharmaceutical worth $362 as of Q2 2026.
Collegium Pharmaceutical was a new Plante Moran Financial Advisors position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1236 holding.
112 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.